Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.36 USD | +2.87% | +4.67% | -26.06% |
04-20 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
04-20 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.06% | 4.43B | |
+27.89% | 49.18B | |
+0.73% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.51% | 18.71B | |
+7.97% | 13.26B | |
+32.26% | 12.32B | |
-0.34% | 11.99B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Piper Sandler Adjusts Immunovant's Price Target to $57 From $28, Maintains Overweight Rating